Volitionrx (VNRX) EBIAT (2019 - 2025)
Volitionrx's EBIAT history spans 9 years, with the latest figure at -$6.3 million for Q4 2025.
- For Q4 2025, EBIAT fell 8.24% year-over-year to -$6.3 million; the TTM value through Dec 2025 reached -$23.4 million, up 13.66%, while the annual FY2025 figure was -$23.4 million, 13.39% up from the prior year.
- EBIAT reached -$6.3 million in Q4 2025 per VNRX's latest filing, down from -$5.4 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $137.0 million in Q4 2021 to a low of -$9.6 million in Q2 2023.
- Average EBIAT over 5 years is $436687.6, with a median of -$6.7 million recorded in 2024.
- Peak YoY movement for EBIAT: skyrocketed 575941.71% in 2021, then tumbled 9452.23% in 2023.
- A 5-year view of EBIAT shows it stood at $137.0 million in 2021, then tumbled by 99.93% to $94092.0 in 2022, then crashed by 9452.23% to -$8.8 million in 2023, then skyrocketed by 34.16% to -$5.8 million in 2024, then decreased by 8.24% to -$6.3 million in 2025.
- Per Business Quant, the three most recent readings for VNRX's EBIAT are -$6.3 million (Q4 2025), -$5.4 million (Q3 2025), and -$6.3 million (Q2 2025).